This study is in progress, not accepting new patients
JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF
Summary
- Eligibility
- for people ages 40-80 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Nitto Denko Corporation
- ID
- NCT03538301
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 120 study participants
- Last Updated